Golden Throat Holdings Group Company Limited

HKSE 6896.HK

Golden Throat Holdings Group Company Limited EPS (Diluted) for the year ending December 31, 2023: USD 0.05

Golden Throat Holdings Group Company Limited EPS (Diluted) is USD 0.05 for the year ending December 31, 2023, a -13.03% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Golden Throat Holdings Group Company Limited EPS (Diluted) for the year ending December 31, 2022 was USD 0.06, a 39.96% change year over year.
  • Golden Throat Holdings Group Company Limited EPS (Diluted) for the year ending December 31, 2021 was USD 0.04, a 22.30% change year over year.
  • Golden Throat Holdings Group Company Limited EPS (Diluted) for the year ending December 31, 2020 was USD 0.03, a -2.59% change year over year.
  • Golden Throat Holdings Group Company Limited EPS (Diluted) for the year ending December 31, 2019 was USD 0.03, a 62.25% change year over year.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
SV Wall Street
HKSE: 6896.HK

Golden Throat Holdings Group Company Limited

CEO Mr. Yong Zeng
IPO Date July 15, 2015
Location China
Headquarters No.28 Yuejin Road
Employees 874
Sector Consumers Staples
Industries
Tobacco Consumer Packaged Goods Drugstores & Retail Pharmacies Non-Alcoholic Beverages Perfumes & Fragrances Personal Care Pharmaceuticals Soft Drinks & Sodas
Description

Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet, which is designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats. The company also exports its products to the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.

Similar companies

6826.HK

Shanghai Haohai Biological Technology Co., Ltd.

USD 3.18

-2.77%

StockViz Staff

February 3, 2025

Any question? Send us an email